Ben & Jerry’s independent board chair Anuradha Mittal says she will not resign despite increasing pressure from Unilever just days before Magnum’s public spinoff. The new standalone company, which will include the Vermont-based Ben & Jerry’s brand, is set to list on Euronext on Monday and will inherit an ongoing feud between Unilever and the ice cream maker’s socially progressive board.
Magnum stated last month that Mittal “no longer meets the criteria” to serve following internal investigations but did not reveal details. The tension escalates as Ben & Jerry’s continues to take outspoken positions on political issues, particularly regarding the Israeli-occupied Palestinian territories—views Unilever argues have created reputational and operational risks. Securities filings for Magnum warn that Ben & Jerry’s activism could lead to investor challenges, public backlash, or boycotts.
Mittal, who has chaired Ben & Jerry’s independent board since 2018 and also serves as a trustee of the Ben & Jerry’s Foundation, dismissed the audit of the U.S.-based nonprofit as a “manufactured inquiry” designed to discredit her and weaken the board’s authority. She emphasized that her role is defined in Ben & Jerry’s 2000 merger agreement with Unilever, which grants the board unique oversight over the brand’s social mission and product quality.
The foundation’s trustees said they were informed that Unilever and Magnum want Mittal removed as a trustee and alleged that both companies have withheld required funding despite the foundation’s cooperation with the audit. The board’s counsel criticized Unilever, suggesting either decades-long neglect or an ulterior motive behind the sudden scrutiny of governance practices that have been unchanged for over 20 years.
As Magnum prepares to command roughly 20% of the global ice cream market as a standalone entity, the corporate rift shows no signs of cooling, setting the stage for further conflict between the brand’s social mission and Unilever’s corporate strategy.


Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



